Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00710515
What this trial is testing

Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies

Who this might be right for
MelanomaMalignant Melanoma
AstraZeneca 30
Early research (Phase 1)Study completedNCT00969410
What this trial is testing

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

Who this might be right for
Malignant Solid TumourLiver Metastases
AVEO Pharmaceuticals, Inc. 19
Early research (Phase 1)Looking for participantsNCT07603479
What this trial is testing

JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
MalignanciesSolid Malignant TumorNHL (Non-Hodgkin Lymphoma)+1 more
Jecho Biopharmaceuticals Co., Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Looking for participantsNCT07137416
What this trial is testing

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+13 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT03383692
What this trial is testing

Study of DS-8201a for Participants With Advanced Solid Malignant Tumors

Who this might be right for
Neoplasm Metastasis
Daiichi Sankyo Co., Ltd. 40
Early research (Phase 1)UnknownNCT05046847
What this trial is testing

A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors

Who this might be right for
Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Early research (Phase 1)Study completedNCT03553108
What this trial is testing

A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

Who this might be right for
Malignant Solid Tumor
AstraZeneca 18
Early research (Phase 1)Study completedNCT02141347
What this trial is testing

Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma

Who this might be right for
Part A and B: Advanced Solid MalignanciesPart C: Malignant Mesothelioma
AstraZeneca 65
Testing effectiveness (Phase 2)Study completedNCT06238687
What this trial is testing

STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors

Who this might be right for
Neoplasm Malignant
Tasly Pharmaceutical Group Co., Ltd 19
Testing effectiveness (Phase 2)Study completedNCT00786838
What this trial is testing

Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram

Who this might be right for
Solid Tumor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 76
Testing effectiveness (Phase 2)Looking for participantsNCT07299747
What this trial is testing

Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc 255
Early research (Phase 1)Study completedNCT01596140
What this trial is testing

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

Who this might be right for
Advanced CancerSolid Tumor
M.D. Anderson Cancer Center 27
Early research (Phase 1)Study completedNCT00942799
What this trial is testing

Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Genzyme, a Sanofi Company 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390852
What this trial is testing

Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Not Yet RecruitingNCT07028047
What this trial is testing

Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study

Who this might be right for
Advanced EBV-positive Malignant Solid Tumors
Sun Yat-sen University 64
Testing effectiveness (Phase 2)Ended earlyNCT02440685
What this trial is testing

Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Who this might be right for
Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Follicular+18 more
Asana BioSciences 51
Early research (Phase 1)Study completedNCT03756818
What this trial is testing

TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmOvarian CarcinomaRefractory Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)Looking for participantsNCT05705492
What this trial is testing

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Biliary Tract CarcinomaAdvanced Esophageal Carcinoma+7 more
OHSU Knight Cancer Institute 66
Early research (Phase 1)Looking for participantsNCT06418061
What this trial is testing

Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
UnresectableLocally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 198
Next Page